Risky Business (The Deal)

Central clearing for OTC derivatives has become a pretty competitive business, driven mostly by soon to be in place regulatory mandates. ┬áThis story digs into LCH.Clearnet’s postion now and going forward:

“One of the biggest things holding them back is that they’re still viewed as a dealer’s club,” McPartland says. In contrast, he says the smaller New York-based IDCG “is viewed more as a newer independent player.

Read the full story at thedeal.com

Leave a Reply

Your email address will not be published.